193 related articles for article (PubMed ID: 33664368)
21. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
22. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
23. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
24. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia.
Thielemans N; Demeyer S; Mentens N; Gielen O; Provost S; Cools J
Haematologica; 2022 Oct; 107(10):2304-2317. PubMed ID: 35354248
[TBL] [Abstract][Full Text] [Related]
25. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
[TBL] [Abstract][Full Text] [Related]
26. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
Yang R; Ai Y; Bai T; Lu XX; He G
Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
[TBL] [Abstract][Full Text] [Related]
27. ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
Costa JR; Mansour MR
Haematologica; 2024 May; 109(5):1325-1327. PubMed ID: 38105739
[No Abstract] [Full Text] [Related]
28. Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein.
Park HB; Min Y; Hwang S; Baek KH
Biomed Pharmacother; 2023 Jun; 162():114700. PubMed ID: 37062218
[TBL] [Abstract][Full Text] [Related]
29. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
30. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
31. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
[TBL] [Abstract][Full Text] [Related]
32. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
Ono Y; Fukuhara N; Yoshie O
Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
[TBL] [Abstract][Full Text] [Related]
33. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
Jenkins CE; Gusscott S; Wong RJ; Shevchuk OO; Rana G; Giambra V; Tyshchenko K; Islam R; Hirst M; Weng AP
Exp Hematol; 2018 Aug; 64():84-96. PubMed ID: 29733873
[TBL] [Abstract][Full Text] [Related]
35. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.
Bornschein S; Demeyer S; Stirparo R; Gielen O; Vicente C; Geerdens E; Ghesquière B; Aerts S; Cools J; de Bock CE
Leukemia; 2018 Apr; 32(4):941-951. PubMed ID: 29151585
[TBL] [Abstract][Full Text] [Related]
36. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL).
Nagel S; Ehrentraut S; Tomasch J; Lienenklaus S; Schneider B; Geffers R; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
PLoS One; 2012; 7(7):e40747. PubMed ID: 22848398
[TBL] [Abstract][Full Text] [Related]
38. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
[TBL] [Abstract][Full Text] [Related]
39. Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.
Zhou Y; Han C; Wang E; Lorch AH; Serafin V; Cho BK; Gutierrez Diaz BT; Calvo J; Fang C; Khodadadi-Jamayran A; Tabaglio T; Marier C; Kuchmiy A; Sun L; Yacu G; Filip SK; Jin Q; Takahashi YH; Amici DR; Rendleman EJ; Rawat R; Bresolin S; Paganin M; Zhang C; Li H; Kandela I; Politanska Y; Abdala-Valencia H; Mendillo ML; Zhu P; Palhais B; Van Vlierberghe P; Taghon T; Aifantis I; Goo YA; Guccione E; Heguy A; Tsirigos A; Wee KB; Mishra RK; Pflumio F; Accordi B; Basso G; Ntziachristos P
Cancer Discov; 2020 Sep; 10(9):1388-1409. PubMed ID: 32444465
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
